Notice of Investor Relations Meeting… Schedule for Communication with Investors


  • Hanall Biopharma will hold an NDR (Non-Deal Roadshow) for domestic institutional investors from May 29 to June 2, 2026.
  • This IR event, sponsored by Hyundai Motor Securities, will include a presentation on current business status and a Q&A session.
  • Related IR materials are available on the company's website under the investor relations section.
  • [AI Comprehensive Analysis]This disclosure is a routine notice of investor communication activities, with limited direct impact on short-term stock price.

KOSPI Filing Information


  • Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
  • Company: Hanall Biopharma (009420)
  • Submission: Hanall Biopharma Co., Ltd.
  • Receipt: 05-28-2026
  • Under KRX KOSPI Market Division